K-Filler Going Global

Samyang Holdings is targeting Indonesia, China, and other countries.

Hugel, Seegene Bio, and Bioplus are expanding beyond Asia to Europe, the Middle East, and South America.

​

- The domestic filler market is estimated to be 140 billion to 160 billion won.

- China's medical beauty market is expected to reach 61 trillion won this year.

Seegene Bio

• Acquired approval for HA filler 'Eilin' in Australia.
• Entered about 31 global markets.
• Australia's cosmetic surgery market was approximately 5 trillion won in 2022.
  

Bioplus

• HA filler 'Dermal Filler'
• - Approval for product listing in Brazil has been completed, and sales are planned.
  
• - Product listing approvals have been completed and market entry has been achieved in major South American countries such as Argentina, Peru, Colombia, and Ecuador.

Humedix

• Developing the Chinese, Brazilian, and South American markets.
• A subsidiary of Huons Global.

Samyang Holdings

• High-end filler market (PCL) 'Lapuler'
• - It lasts for over two years due to the presence of polymer material. It is said to last twice as long as hyaluronic acid.
  
• - It has been recognized for its excellence by presenting research results proving its long-term effects and safety in SCI-level international journals.
  
• It is the only PCL filler supplier in Korea, and the only two products are 'Elancé' from the British pharmaceutical company Sinclair.
  
• The polymer filler market accounts for about 10% of the total filler market. It is non-reimbursable. The price is also higher than HA.
  
• - Product listing approval in Indonesia was completed in April 2023 and launched in June.​
• - In May 2023, Samyang Holdings signed a partnership agreement with Hangzhou Yishinten, a Chinese medical device and aesthetics company.

Written by 2023.12.13